Benzinga | Jul 13, 2020 06:14AM EDT

Axonics Modulation Tech Sees Q2 Sales $15.200M vs $5.19M Est

Axonics Modulation Tech (NASDAQ:AXNX) sees Q2 sales of $15.200 million vs $5.19 million estimate.